Baby teeth stem cells tested as possible ALS treatment
Disease control
Ongoing
This early-phase trial tests a substance made from stem cells from baby teeth (SHED-CM) in 10 people with ALS. The goal is to see if it is safe and if it might slow the disease. Participants receive the treatment intravenously over 12 weeks, with follow-up for 4 more weeks.
Phase: EARLY_PHASE1 • Sponsor: Hitonowa Medical • Aim: Disease control
Last updated Jun 26, 2026 17:16 UTC